Imunon, Inc. (IMNN)
1.555
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
1.555
0.00 (0.00%)
After-Hours: 20:00
Imunon Cash from Operations (Annual) : -13.90M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.90M |
| December 31, 2024 | -18.86M |
| December 31, 2023 | -19.02M |
| December 31, 2022 | -23.13M |
| December 31, 2021 | -16.22M |
| December 31, 2020 | -15.62M |
| December 31, 2019 | -20.26M |
| December 31, 2018 | -7.042M |
| December 31, 2017 | -16.64M |
| December 31, 2016 | -18.38M |
| December 31, 2015 | -20.83M |
| December 31, 2014 | -21.35M |
| December 31, 2013 | -9.472M |
| December 31, 2012 | -22.33M |
| Date | Value |
|---|---|
| December 31, 2011 | -22.74M |
| December 31, 2010 | -13.37M |
| December 31, 2009 | -0.9303M |
| December 31, 2008 | 2.281M |
| December 31, 2007 | -9.583M |
| December 31, 2006 | -7.233M |
| December 31, 2005 | -8.065M |
| December 31, 2004 | -13.94M |
| September 30, 2003 | -9.088M |
| September 30, 2002 | -9.112M |
| September 30, 2001 | -6.224M |
| September 30, 2000 | -3.866M |
| September 30, 1999 | -2.283M |
| September 30, 1998 | -2.112M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Phio Pharmaceuticals Corp. | -7.979M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |
| BioCryst Pharmaceuticals, Inc. | 329.88M |